Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 4Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 2Genitourinary 2Sarcoma 1Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Multiple Myeloma 1Infections 1

Interventions

Dexamethasone 393Bortezomib 246Lenalidomide 222Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 58Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Trimethoprim, Sulfamethoxazole Drug Combination × Plasma cell × Clear all
NCT00002850 2015-11-11

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

University of Rochester

Phase 3 Completed
212 enrolled 12 charts
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡